CIPLA IRINOTECAN 40 mg/2 ml


Solution for Infusion
scheduling status
S4
registration number
41/26/0049
What CIPLA IRINOTECAN 40 mg/2 ml contains
Irinotecan hydrochloride trihydrate.
other ingredients
Lactic Acid, Sodium Hydroxide (0,1 N), Sorbitol and Water for Injection.
Therapeutic classification
A.20 Cytostatic Agents.
© 2026 SAHPRA. ALL RIGHTS RESERVED